Collegium Pharma (COLL) Posts Q1 Loss of $0.29/Sh

Collegium Pharma (NASDAQ: COLL) reported Q1 EPS of ($0.29), which may not compare to the analyst estimate of ($0.24). Revenue for the quarter came in at $74.5 million versus the consensus estimate of $70.82 million.

For earnings history and earnings-related data on Collegium Pharma (COLL) click here.

You May Also Be Interested In

• KB Home (KBH) Tops Q3 EPS by 16c
• AutoZone (AZO) Tops Q4 EPS by $1.76, Misses on Revenue
• UBS Reiterates Neutral Rating on Pilgrim's Pride (PPC) on 'Challenging' Near-Term Fundamentals